NEE
50
-5
CRM
67
2
HCP
66
8
CA
38
6
UPS
60
9
FLR
58
3
PG
56
5
EL
25
4
HD
57
2
LMT
34
2
F
58
11
IPG
56
3
XRX
44
3
MLM
57
6
A
43
2
NWL
53
3
STI
14
-17
MTB
67
2
NDAQ
62
2
VTR
47
-7
NEE
50
-5
CRM
67
2
HCP
66
8
CA
38
6
UPS
60
9
FLR
58
3
PG
56
5
EL
25
4
HD
57
2
LMT
34
2
F
58
11
IPG
56
3
XRX
44
3
MLM
57
6
A
43
2
NWL
53
3
STI
14
-17
MTB
67
2
NDAQ
62
2
VTR
47
-7
Financhill
Back

Replimune Group 10K Form

Buy
56

REPL
Replimune Group

Last Price:
14.93
Seasonality Move:
-7.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales: $4.95K
Cash Flow: $-40.72M
Price / Cash Flow: 0
Annual Sales: $5.58
Price / Book: 2.68

Profitability

EPS (TTM): -3.05000
Net Income (TTM): $-213.02M
Gross Margin: $4.95K
Return on Equity: 0%
Return on Assets: 0%

Replimune Group Earnings Forecast

Key Replimune Group Financial Ratios

  • The Gross Profit Margin over the past 1 years for REPL is 100.00%.
  • The Selling, General & Administrative Expenses for REPL have been equal to 1,021,272.73% of Gross Profit Margin.
  • The Interest Expense is -3.09% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Replimune Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: REPL
CUSIP: 76029N
Website: replimune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

REPL Technical Analysis vs Fundamental Analysis

Buy
56
Replimune Group (REPL) is a Buy

Is Replimune Group a Buy or a Sell?

  • Replimune Group stock is rated a Buy
    The current Replimune Group [REPL] share price is $14.93. The Score for REPL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.